	US 12,076,359 B2
	*Pharmaceutical composition comprising a fraction of Melissa officinalis* leaf extract**
Min-Young Kim, Daejeon (KR); Byung Young Park, Daejeon (KR); Hee Suk Lee, Daejeon (KR); Hyung Soo Yuh, Sejong-Si (KR); Jeong Eun Kim, Daejeon (KR); and Hyun Jeung Kim, Daejeon (KR)
Assigned to ANGIOLAB, INC., Daejeon (KR)
Filed by ANGIOLAB, INC., Daejeon (KR)
Filed on Oct. 17, 2023, as Appl. No. 18/381,023.
Application 18/381,023 is a division of application No. 17/427,168, abandoned, previously published as PCT/KR2020/006669, filed on May 21, 2020.
Claims priority of application No. 10-2019-0060305 (KR), filed on May 22, 2019.
Prior Publication US 2024/0041965 A1, Feb. 8, 2024
Int. Cl. A61K 36/53 (2006.01); A61P 27/16 (2006.01)

CPC A61K 36/53 (2013.01) [A61P 27/16 (2018.01); A61K 2236/333 (2013.01); A61K 2236/39 (2013.01); A61K 2236/51 (2013.01)]

3 Claims

1. A method for preventing or treating otitis media with effusion, the method comprising:

administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a fraction of Melissa officinalis leaf extract.